Validation of three coding algorithms to identify patients with end‐stage liver disease in an administrative database

Use of administrative or population‐based databases for post‐marketing pharmacoepidemiology research in patients with end‐stage liver disease (ESLD) has been limited by the difficulty of accurately identifying such patients. Algorithms to identify patients with ESLD using ICD‐9‐CM codes have not been developed outside of the Veterans Affairs healthcare setting.

[1]  F. Pruvot,et al.  Early liver transplantation for severe alcoholic hepatitis. , 2011, The New England journal of medicine.

[2]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[3]  H. El‐Serag,et al.  The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases , 2007, Alimentary pharmacology & therapeutics.

[4]  S. Friedman,et al.  Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis , 2010, Hepatology.

[5]  A. Burroughs,et al.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. , 2010, Gastroenterology.

[6]  I. Gareen,et al.  National Institutes of Health consensus development conference statement: Management of hepatitis B , 2009, Hepatology.

[7]  Farah Kidwai,et al.  Validity of diagnostic codes and liver‐related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study , 2011, Pharmacoepidemiology and drug safety.

[8]  Hepatitis C--global prevalence (update). , 2000, Releve epidemiologique hebdomadaire.

[9]  M. Kudo,et al.  Diagnostic Accuracy of Imaging for Liver Cirrhosis Compared to Histologically Proven Liver Cirrhosis , 2008, Intervirology.

[10]  R. Carithers,et al.  Practice Guidelines : Evaluation of the Patient for Liver Transplantation , 2005 .

[11]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[12]  Fangjun Zhou,et al.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.

[13]  M. Manos,et al.  The Epidemiology of Newly Diagnosed Chronic Liver Disease in Gastroenterology Practices in the United States: Results From Population-Based Surveillance , 2008, The American Journal of Gastroenterology.

[14]  W. Kim,et al.  Burden of liver disease in the United States: Summary of a workshop , 2002, Hepatology.

[15]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.